Cubist Systematic Strategies, LLC Maxcyte, Inc. Transaction History

Cubist Systematic Strategies, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$4.03 - $5.89 $50,431 - $73,707	12,514 Added 5302.54%	12,750 $63,000
Q4 2022 Feb 14, 2023	SELL	$4.92 - $7.4 $64,068 - $96,362	-13,022 Reduced 98.22%	236 $1,000
Q3 2022 Nov 14, 2022	BUY	$4.52 - $6.51 $9,044 - $13,026	2,001 Added 17.78%	13,258 $86,000
Q2 2022 Aug 15, 2022	SELL	$3.59 - $6.81 $55,978 - $106,188	-15,593 Reduced 58.07%	11,257 $53,000
Q1 2022 May 16, 2022	BUY	$5.26 - $10.84 $141,231 - $291,054	26,850 New	26,850 $188,000
Q4 2021 Feb 14, 2022	SELL	$8.87 - $12.94 $280,292 - $408,904	-31,600 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$12.21 - $17.2 $385,836 - $543,520	31,600 New	31,600 $386,000

124

65.6M

Ticker MXCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 101,724,000
Market Cap $451M
Description
MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.